Adi Eisenberg

Multiple Morphologies of "Crew-Cut" Aggregates of Polystyrene-b-poly(acrylic acid) Block Copolymers

The observation by transmission electron microscopy of six different stable aggregate morphologies is reported for the same family of highly asymmetric polystyrene-poly-(acrylic acid) block copolymers prepared in a low molecular weight solvent system. Four of the morphologies consist of spheres, rods, lamellae, and vesicles in aqueous solution, whereas the fifth consists of simple reverse micelle-like aggregates. The sixth consists of up to micrometer-size spheres in aqueous solution that have hydrophilic surfaces and are filled with the reverse micelle-like aggregates. In addition, a needle-like solid, which is highly birefringent, is obtained on drying of aqueous solutions of the spherical micelles. This range of morphologies is believed to be unprecedented for a block copolymer system.

Nano-engineering block copolymer aggregates for drug delivery

Abstract This review describes the properties of block copolymer micelles which influence their efficiency as drug delivery vehicles for hydrophobic drugs. The key performance related properties we discuss are loading capacity, release kinetics, circulation time, biodistribution, size, size distribution and stability. Each of the properties is discussed in detail with specific attention given to the way in which they may be changed or controlled, the aim being to allow the reader to tailor-make block copolymer micelles for a particular application. In addition, the last section of the review focuses on the morphology of the micelles as another performance related property which, to this point, remains unexplored in this connection.

Ion-Induced Morphological Changes in “Crew-Cut” Aggregates of Amphiphilic Block Copolymers

The addition of ions in micromolar (CaCl2 or HCl) or millimolar (NaCl) concentrations can change the morphology of “crew-cut” aggregates of amphiphilic block copolymers in dilute solutions. In addition to spherical, rodlike, and univesicular or lamellar aggregates, an unusual large compound vesicle morphology can be obtained from a single block copolymer. Some features of the spontaneously formed large compound vesicles may make them especially useful as vehicles for delivering drugs and as models of biological cells. Gelation of a dilute spherical micelle solution can also be induced by ions as the result of the formation of a cross-linked “pearl necklace” morphology.

Introduction to Ionomers

Structural Variability in Ionomers. Morphology of Random Ionomers. Glass Transitions in Random Ionomers. Styrene Ionomers. Partly Crystalline Ionomers. Other Ionomers. Plasticization. Ionomer Blends. Applications. Index.

Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone.

Block copolymer micelles formed from copolymers of poly(caprolactone)-b-poly(ethylene oxide) (PCL-b-PEO) were investigated as a drug delivery vehicle for dihydrotestosterone (DHT). The physical parameters of the PCL-b-PEO micelle-incorporated DHT were measured, including the loading capacity of the micelles for DHT, the apparent partition coefficient of DHT between the micelles and the external medium and the kinetics of the release of DHT from the micelle solution. The MTT survival assay was used to assess the in vitro biocompatibility of PCL-b-PEO micelles in HeLa cell cultures. The biological activity of the micelle-incorporated DHT was evaluated in HeLa cells which had been co-transfected with the expression vectors for the androgen receptor and the MMTV-LUC reporter gene. The PCL-b-PEO micelles were found to have a high loading capacity for DHT and the release profile of the drug from the micelle solution was found to be a slow steady release which continued over a 1-month period. The biological activity of the micelle-incorporated DHT was found to be fully retained.

Block copolymer micelles as delivery vehicles of hydrophobic drugs: Micelle–cell interactions

One-third of drugs in development are water insoluble and one-half fail in trials because of poor pharmacokinetics. Block copolymer micelles are nanosized particles that can solubilize hydrophobic drugs and alter their kinetics in vitro and in vivo. However, block copolymer micelles are not solely passive drug containers that simply solubilize hydrophobic drugs; cells internalize micelles. To facilitate the development of advanced, controlled, micellar drug delivery vehicles, we have to understand the fate of micelles and micelle-incorporated drugs in cells and in vivo. With micelle-based drug formulations recently reaching clinical trials, the impetus for answers is ever so strong and detailed studies of interactions of micelles and cells are starting to emerge. Most notably, the question arises: Is the internalization of block copolymer micelles carrying small molecular weight drugs an undesired side effect or a useful means of improving the effectiveness of the incorporated drugs?

Controlled Incorporation of Particles into the Central Portion of Vesicle Walls

Vesicles have attracted considerable attention recently because of many potential applications as well as intrinsic interest in the structures. The incorporation of various particles into vesicle walls has also received attention. One of the unsolved problems, in this context, is the controlled incorporation of particles into only the central portion of the vesicle walls, i.e. approximately halfway between the external and internal interfaces. In this paper, we describe a general method for the incorporation of particles into only the central portion, i.e. central 10-20%, of the vesicle walls. The strategy involves the use, as coatings on the particles, of diblock copolymers of a structure similar to that of the vesicle formers, which allows the particles to be preferentially localized in the central portion of the walls.

Selective Localization of Preformed Nanoparticles in Morphologically Controllable Block Copolymer Aggregates in Solution

The development of nanodevices currently requires the formation of morphologically controlled or highly ordered arrays of metal, semiconducting, or magnetic nanoparticles. In this context, polymer self-assembly provides a powerful bottom-up approach for constructing these materials. The self-assembly of block copolymers (BCPs) in solution is a facile and popular method for the preparation of aggregates of controllable morphologies, including spherical micelles, cylindrical micelles, vesicles (or polymersomes), thin films, and other complex structures that range from zero to three dimensions. Researchers can generally control the morphology of the aggregates by varying copolymer composition or environmental parameters, including the copolymer concentration, the common solvent, the content of the precipitant, or the presence of additives such as ions, among others. For example, as the content of the hydrophilic block in amphiphilic copolymers decreases, the aggregates formed from the copolymers can change from spherical micelles to cylindrical micelles and to vesicles. The aggregates of various morphologies provide excellent templates for the organization of the nanoparticles. The presence of various domains, such as cores, interfaces, and coronas, in BCP aggregates allows for selective localization of nanoparticles in different regions, which may critically affect the resulting properties and applications of the nanoparticles. For example, the incorporation of quantum dots (QDs) into micelle cores solves many problems encountered in the utilization of QDs in biological environments, including enhancement of water solubility, aggregation prevention, increases in circulation or retention time, and toxicity clearance. Simultaneously it preserves the unique optical performance of QDs compared with those of organic fluorophores, such as size-tunable light emission, improved signal brightness, resistance against photobleaching, and simultaneous excitation of multiple fluorescence colors. Therefore, many studies have focused on the selective localization of nanoparticles in BCP aggregates. This Account describes the selective localization of preformed spherical nanoparticles in different domains of BCP aggregates of controllable morphologies in solution, including spherical micelles, cylindrical micelles, and vesicles. These structures offer many potential applications in biotechnology, biomedicine, catalysis, etc. We also introduce other types of control, including interparticle spacing, particle number density, or aggregate size control. We highlight examples in which the surface coating, volume fraction, or size of the particles was tailored to precisely control incorporation. These examples build on the thermodynamic considerations of particle-polymer interactions, such as hydrophobic interactions, hydrogen bonding, electrostatic interactions, and ligand replacement, among others.

CELLULAR INTERNALIZATION OF PCL20-B-PEO44 BLOCK COPOLYMER MICELLES

The cellular internalization of polycaprolactone-b-poly(ethylene oxide) (PCL(20)-b-PEO(44)) copolymer micelles were investigated in PC12 cells cultures. The micelles were found to be internalized into PC12 cells when followed over the 4-h incubation period. Also, the internalization process was found to fulfill the basic criteria for endocytotic uptake in that it was time, temperature, pH and energy dependent. In addition, the use of other pharmacological manipulations (hypertonic treatment, Brefeldin A) provide further evidence that the mode of cellular internalization is in fact endocytotic.

NOVEL DRUG DELIVERY SYSTEMS BASED ON THE COMPLEXES OF BLOCK IONOMERS AND SURFACTANTS OF OPPOSITE CHARGE

Abstract In this paper we have evaluated a novel family of polymer-surfactant complexes formed between block ionomers and oppositely charged surfactants. Complexes between cationic copolymer poly(ethylene oxide)- g -polyethyleneimine (PEO- g -PEI) and sodium salt of oleic acid, natural nontoxic surfactant, are prepared and characterized. These systems self-assemble in aqueous solutions into particles with average size of 50–60 nm, which can solubilize hydrophobic dyes (Yellow OB) and drug molecules (paclitaxel). The use of the biologically active surfactants as components of block ionomer complexes is demonstrated for the complexes from PEO- g -PEI and all- trans -retinoic acid. Binding of relatively soluble drugs with block ionomers is illustrated using PEO- b -poly(sodium methacrylate) and doxorubicin. Overall these studies suggest that block ionomer complexes can be used to prepare a variety of soluble and stable formulations of biologically active compounds, and have potential application as drug delivery systems